The new heart 🫀transplant guidelines are out! 🚨So grateful to collaborate with this fantastic team of co-authors! ⁦@ISHLT⁩

Marjorie Taylor Greene doesn't want you to know the name of her opponent but will try every desperate attempt to save her seat. My name is Shawn Harris. I am a Democrat, husband, father, retired General, farmer, and I'm running against MTG. Can you retweet and spread the word?

Ivabradine: Beyond Heart Failure—Exploring New Clinical Uses 💊❤️ https://t.co/ma6NVg8FSJ @AzitaTalasaz @ZahraGkhan @Prof_J_NYC #Ivabradine #HeartFailure #HeartRate #CardiovascularHealth #POTS

Xena presenting our work looking at immunosupression in dual heart-kidney recipients before and after the @UNOSNews allocation change. @Prof_J_NYC @UConnPharmacy @LIUPharmacy #ACCPAM24

The Difference Between Cystatin C– and Creatinine-Based eGFR in Heart Failure With Reduced Ejection Fraction https://t.co/CYJhGP878D @AlbertoPinsino @SAHusainMD @SumitMohanMD @jradnephro @Prof_J_NYC @asnguonly @LorenzoBragh @gtsayer @NirUrielMD @yuzefpolskaya @ColumbiaKidney

Congratulations to the @SemThrombHemost 2022 Eberhard F. Mammen Young Investigator Award recipients! Rayna Anjis, @AislingRehill, @HarveyRoweth , @PoolePAR_ty, @AzitaTalasaz and Stefano Lancellotti 👏👏👏 https://t.co/IzbhFHQna8

Addition of hydrocortisone to norepinephrine was associated with a lower 28-day mortality in patients with septic shock, compared to the addition of vasopressin. https://t.co/vb4nsanNnc @accpcritprn

Michael Kirschner presenting our comparison between heart transplant to LVAD study, led by Dr. Takeda! kudos for amazing presentation! @gtsayer @dor_lotan @VeliKTopkaraMD #ISHLT2023 @CUMCHeartSource @ColumbiaMed @ColumbiaSurgery @AHajduczok @MRMehraMD @DrJennHaythe

@Prof_J_NYC is a co-author on this up-coming paper based on the conference. #ISHLT2023

Co-moderated by the one and only @Prof_J_NYC

A medical breakthrough for patients, FK-506 was a more effective and potent immunosuppressant than what had been used previously. Dr. Starzl and his team of researchers were instrumental in its development and in providing support for its widespread use.

Hot off the press at JCF: HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support @preventfailure @Prof_J_NYC @RenzoLoyaga @rcogswell_umn @LiviuKlein @PalakShahMD @michaelkiernan @VorovichHeartMD https://t.co/8OAlglqLh4

Shout out to @Prof_J_NYC for co-authoring this @HFSA consensus statement. Looks incredible. @accpcardprn HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support

Immunosuppression use & differences between agents in adult heart transplant recipients before and after the UNOS allocation policy change. https://t.co/v8EXYYTSro @wbaker0621 @Prof_J_NYC @UConnPharmacy @accpcardprn @accpimtrprn

Don’t forget dyspnea!

Combine short and long acting opioids!

Treat pain aggressively!

https://t.co/pcOsGOkARE

Stay humble!

#twitterx

Respect your patients cultural differences when approaching pal care discussions!